{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:17:34Z","timestamp":1791317854976,"version":"4.3.1"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100789"],"award-info":[{"award-number":["82100789"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022JJ40378"],"award-info":[{"award-number":["2022JJ40378"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cca.2025.120574","type":"journal-article","created":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T21:48:27Z","timestamp":1756072107000},"page":"120574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["High-density lipoprotein in cardiovascular diseases: From high quantity to high quality"],"prefix":"10.1016","volume":"578","author":[{"given":"Yifang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.cca.2025.120574_b0005","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","author":"Bowman","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.cca.2025.120574_b0010","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.cca.2025.120574_b0015","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"Evacetrapib and cardiovascular outcomes in high-risk vascular disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.cca.2025.120574_b0020","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2025.120574_b0025","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/296417","article-title":"Dysfunctional high-density lipoprotein: an innovative target for proteomics and lipidomics","volume":"2015","author":"Salazar","year":"2015","journal-title":"Cholesterol"},{"issue":"5","key":"10.1016\/j.cca.2025.120574_b0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11883-004-0047-0","article-title":"High-density lipoprotein subfractions and risk of coronary artery disease","volume":"6","author":"Morgan","year":"2004","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.cca.2025.120574_b0035","article-title":"The value of HDL subfractions in predicting cardiovascular outcomes in untreated, diabetic patients with stable coronary artery disease: an age- and gender-matched case-control study","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol. (lausanne)"},{"issue":"1","key":"10.1016\/j.cca.2025.120574_b0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.atherosclerosis.2012.08.040","article-title":"HDL2 interferes with LDL association with arterial proteoglycans: a possible athero-protective effect","volume":"225","author":"Umaerus","year":"2012","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.cca.2025.120574_b0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/CIRCRESAHA.114.300632","article-title":"Regulation of high-density lipoprotein metabolism","volume":"114","author":"Rye","year":"2014","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120574_b0050","article-title":"HDL and reverse cholesterol transport in humans and animals: Lessons from pre-clinical models and clinical studies","volume":"1867","author":"Zanotti","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.cca.2025.120574_b0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbacli.2017.07.002","article-title":"Antioxidative activity of high-density lipoprotein (HDL): mechanistic insights into potential clinical benefit","volume":"8","author":"Brites","year":"2017","journal-title":"BBA Clin."},{"issue":"12","key":"10.1016\/j.cca.2025.120574_b0060","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1161\/ATVBAHA.119.313253","article-title":"Anti-inflammatory effects of HDL (high-density lipoprotein) in macrophages predominate over proinflammatory effects in atherosclerotic plaques","volume":"39","author":"Fotakis","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.cca.2025.120574_b0065","first-page":"66","article-title":"Anti-thrombotic properties of high-density lipoprotein","volume":"64","author":"Kurano","year":"2016","journal-title":"Rinsho Byori"},{"issue":"11","key":"10.1016\/j.cca.2025.120574_b0070","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1074\/jbc.M211394200","article-title":"High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases","volume":"278","author":"Mineo","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cca.2025.120574_b0075","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12944-017-0429-2","article-title":"HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium","volume":"16","author":"Ruiz","year":"2017","journal-title":"Lipids Health Dis."},{"issue":"4","key":"10.1016\/j.cca.2025.120574_b0080","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"issue":"9","key":"10.1016\/j.cca.2025.120574_b0085","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI103182","article-title":"The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum","volume":"34","author":"Havel","year":"1955","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2025.120574_b0090","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0076-6879(86)28084-2","article-title":"Nondenaturing polyacrylamide gradient gel electrophoresis","volume":"128","author":"Nichols","year":"1986","journal-title":"Methods Enzymol."},{"issue":"3\u20134","key":"10.1016\/j.cca.2025.120574_b0095","first-page":"171","article-title":"Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy","volume":"48","author":"Otvos","year":"2002","journal-title":"Clin. Lab."},{"issue":"19","key":"10.1016\/j.cca.2025.120574_b0100","doi-asserted-by":"crossref","first-page":"12201","DOI":"10.1016\/S0021-9258(20)71339-6","article-title":"Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but No A-II","volume":"259","author":"Cheung","year":"1984","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cca.2025.120574_b0105","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1073\/pnas.81.5.1356","article-title":"Characteristics of human lipoproteins isolated by selected-affinity immunosorption of apolipoprotein A-I","volume":"81","author":"McVicar","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.cca.2025.120574_b0110","doi-asserted-by":"crossref","first-page":"9930","DOI":"10.1074\/jbc.M312476200","article-title":"Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein","volume":"279","author":"Favari","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cca.2025.120574_b0115","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1194\/jlr.RA119000258","article-title":"Composition-function analysis of HDL subpopulations: influence of lipid composition on particle functionality","volume":"61","author":"Niisuke","year":"2020","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.cca.2025.120574_b0120","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study","volume":"62","author":"Gordon","year":"1977","journal-title":"Am. J. Med."},{"issue":"20","key":"10.1016\/j.cca.2025.120574_b0125","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM198711123172001","article-title":"Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease","volume":"317","author":"Frick","year":"1987","journal-title":"N Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120574_b0130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four Prospective American Studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cca.2025.120574_b0135","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jacl.2013.08.001","article-title":"High-density lipoproteins: a consensus statement from the National Lipid Association","volume":"7","author":"Toth","year":"2013","journal-title":"J. Clin. Lipidol."},{"issue":"32","key":"10.1016\/j.cca.2025.120574_b0140","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehx163","article-title":"Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies","volume":"38","author":"Madsen","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2025.120574_b0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.atherosclerosis.2019.01.035","article-title":"Very high high-density lipoprotein cholesterol is associated with increased all-cause mortality in South Koreans","volume":"283","author":"Oh","year":"2019","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.cca.2025.120574_b0150","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1161\/HYPERTENSIONAHA.122.19912","article-title":"High HDL (high-density lipoprotein) cholesterol increases cardiovascular risk in hypertensive patients","volume":"79","author":"Trimarco","year":"2022","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.cca.2025.120574_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13121175","article-title":"Sex-specific relationships between HDL-cholesterol levels and 10-year mortality in individuals with atherosclerotic cardiovascular disease: a nationwide Cohort study of south Koreans","volume":"13","author":"Yang","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.cca.2025.120574_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155817","article-title":"Nonlinear relationship between high-density lipoprotein cholesterol and cardiovascular disease: an observational and Mendelian randomization analysis","volume":"154","author":"Chen","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2025.120574_b0165","article-title":"Association of high-density lipoprotein cholesterol with all-cause and cause-specific mortality in a chinese population of 3.3 million adults: a prospective cohort study","volume":"42","author":"Lu","year":"2024","journal-title":"Lancet Reg. Health West Pac"},{"key":"10.1016\/j.cca.2025.120574_b0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.amjcard.2021.11.041","article-title":"Very high high-density lipoprotein cholesterol levels and cardiovascular mortality","volume":"167","author":"Liu","year":"2022","journal-title":"Am. J. Cardiol."},{"issue":"11","key":"10.1016\/j.cca.2025.120574_b0175","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1177\/2047487320914756","article-title":"HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies","volume":"27","author":"Zhong","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"1","key":"10.1016\/j.cca.2025.120574_b0180","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12944-020-01413-5","article-title":"A U-shaped association between the LDL-cholesterol to HDL-cholesterol ratio and all-cause mortality in elderly hypertensive patients: a prospective cohort study","volume":"19","author":"Yu","year":"2020","journal-title":"Lipids Health Dis."},{"issue":"8","key":"10.1016\/j.cca.2025.120574_b0185","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1210\/jc.2018-02511","article-title":"High-density lipoprotein cholesterol and all-cause and cause-specific mortality among the elderly","volume":"104","author":"Li","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.cca.2025.120574_b0190","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000519","article-title":"Coronary heart disease risks associated with high levels of HDL cholesterol","volume":"3","author":"Wilkins","year":"2014","journal-title":"J. Am. Heart Assoc."},{"issue":"10","key":"10.1016\/j.cca.2025.120574_b0195","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.2215\/CJN.00730116","article-title":"High density lipoprotein cholesterol and the risk of all-cause mortality among U.S. Veterans","volume":"11","author":"Bowe","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2025.120574_b0200","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2019.01.001","article-title":"HDL cholesterol and ASCVD risk stratification: a debate","volume":"283","author":"Barter","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2025.120574_b0205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2020.04.015","article-title":"High density lipoprotein functionality and cardiovascular events and mortality: a systematic review and meta-analysis","volume":"302","author":"Soria-Florido","year":"2020","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.cca.2025.120574_b0210","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1007\/s00125-007-0718-9","article-title":"Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties","volume":"50","author":"Hoang","year":"2007","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.cca.2025.120574_b0215","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/gerona\/glr016","article-title":"High-density lipoprotein (HDL) from elderly and reconstituted HDL containing glycated apolipoproteins A-I share proatherosclerotic and prosenescent properties with increased cholesterol influx","volume":"66","author":"Park","year":"2011","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"4","key":"10.1016\/j.cca.2025.120574_b0220","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00109-005-0030-4","article-title":"Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL","volume":"84","author":"Zannis","year":"2006","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.cca.2025.120574_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112677","article-title":"LCAT- targeted therapies: Progress, failures and future","volume":"147","author":"Yang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cca.2025.120574_b0230","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.atherosclerosis.2017.01.034","article-title":"SR-BI as target in atherosclerosis and cardiovascular disease - a comprehensive appraisal of the cellular functions of SR-BI in physiology and disease","volume":"258","author":"Hoekstra","year":"2017","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.cca.2025.120574_b0235","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/eurheartj\/ehp399","article-title":"Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors","volume":"31","author":"Chapman","year":"2010","journal-title":"Eur. Heart J."},{"issue":"35","key":"10.1016\/j.cca.2025.120574_b0240","doi-asserted-by":"crossref","first-page":"24020","DOI":"10.1074\/jbc.R114.583658","article-title":"Molecular mechanisms of cellular cholesterol efflux","volume":"289","author":"Phillips","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cca.2025.120574_b0245","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-2275(20)43114-1","article-title":"The plasma lecithins:cholesterol acyltransferase reaction","volume":"9","author":"Glomset","year":"1968","journal-title":"J. Lipid Res."},{"issue":"7","key":"10.1016\/j.cca.2025.120574_b0250","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1172\/JCI57671","article-title":"PON-dering differences in HDL function in coronary artery disease","volume":"121","author":"Mineo","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.cca.2025.120574_b0255","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1172\/JCI42946","article-title":"Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease","volume":"121","author":"Besler","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cca.2025.120574_b0260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbrc.2012.02.103","article-title":"An involvement of SR-B1 mediated PI3K-akt-eNOS signaling in HDL-induced cyclooxygenase 2 expression and prostacyclin production in endothelial cells","volume":"420","author":"Zhang","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.cca.2025.120574_b0265","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1074\/jbc.M109.043869","article-title":"Mechanism and role of high density lipoprotein-induced activation of AMP-activated protein kinase in endothelial cells","volume":"285","author":"Kimura","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cca.2025.120574_b0270","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1194\/jlr.M070706","article-title":"S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: calcium flux and S1PR1 internalization","volume":"58","author":"Lee","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2025.120574_b0275","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3389\/fendo.2018.00645","article-title":"Possible insulinotropic action of apolipoprotein A-I through the ABCA1\/Cdc42\/cAMP\/PKA pathway in MIN6 cells","volume":"9","author":"Matsumura","year":"2018","journal-title":"Front. Endocrinol. (lausanne)"},{"issue":"48","key":"10.1016\/j.cca.2025.120574_b0280","doi-asserted-by":"crossref","first-page":"47890","DOI":"10.1074\/jbc.M306258200","article-title":"Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly","volume":"278","author":"Yamauchi","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cca.2025.120574_b0285","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1194\/jlr.M065797","article-title":"Both STAT3 activation and cholesterol efflux contribute to the anti-inflammatory effect of apoA-I\/ABCA1 interaction in macrophages","volume":"57","author":"Tang","year":"2016","journal-title":"J. Lipid Res."},{"issue":"9","key":"10.1016\/j.cca.2025.120574_b0290","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1074\/jbc.M312571200","article-title":"Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol","volume":"279","author":"Tang","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.cca.2025.120574_b0295","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.016507","article-title":"Anti-inflammatory HDL function, incident cardiovascular events, and mortality: a secondary analysis of the JUPITER randomized clinical trial","volume":"9","author":"Ajala","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"20","key":"10.1016\/j.cca.2025.120574_b0300","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1161\/CIRCULATIONAHA.120.050808","article-title":"High-density lipoprotein anti-inflammatory capacity and incident cardiovascular events","volume":"143","author":"Jia","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cca.2025.120574_b0305","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1172\/JCI83475","article-title":"Serum amyloid a impairs the antiinflammatory properties of HDL","volume":"126","author":"Han","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2025.120574_b0310","doi-asserted-by":"crossref","unstructured":"S. Syed, E. Nissil\u00e4, H. Ruhanen, S. Fudo, M.O. Gayt\u00e1n, et al., Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles, iScience 24(6) (2021) 102535.","DOI":"10.1016\/j.isci.2021.102535"},{"key":"10.1016\/j.cca.2025.120574_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103341","article-title":"Impaired HDL antioxidant and anti-inflammatory functions are linked to increased mortality in acute heart failure patients","volume":"76","author":"Pammer","year":"2024","journal-title":"Redox Biol."},{"issue":"7","key":"10.1016\/j.cca.2025.120574_b0320","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/89986","article-title":"High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase","volume":"7","author":"Yuhanna","year":"2001","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.cca.2025.120574_b0325","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/CIRCULATIONAHA.108.810721","article-title":"Inflammation impairs reverse cholesterol transport in vivo","volume":"119","author":"McGillicuddy","year":"2009","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.cca.2025.120574_b0330","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/01.ATV.0000142804.27420.5b","article-title":"Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease","volume":"24","author":"Brewer","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2025.120574_b0335","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cbi.2016.08.007","article-title":"The effect of HDL-bound and free PON1 on copper-induced LDL oxidation","volume":"257","author":"Bayrak","year":"2016","journal-title":"Chem. Biol. Interact."},{"issue":"7","key":"10.1016\/j.cca.2025.120574_b0340","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.ATV.0000222924.62641.aa","article-title":"Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome","volume":"26","author":"Mackness","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"15","key":"10.1016\/j.cca.2025.120574_b0345","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158596","article-title":"Hypercholesterolemia-induced HDL dysfunction can be reversed: the impact of diet and statin treatment in a preclinical animal model","volume":"23","author":"Schoch","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cca.2025.120574_b0350","article-title":"Understanding myeloperoxidase-induced damage to HDL structure and function in the vessel wall: implications for HDL-based therapies","volume":"11","author":"Marsche","year":"2022","journal-title":"Antioxidants (basel)"},{"issue":"3","key":"10.1016\/j.cca.2025.120574_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101019","article-title":"Myeloperoxidase-induced modification of HDL by isolevuglandins inhibits paraoxonase-1 activity","volume":"297","author":"Aggarwal","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2025.120574_b0360","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-3-319-09665-0_5","article-title":"Functionality of HDL: antioxidation and detoxifying effects","volume":"224","author":"Karlsson","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"issue":"7","key":"10.1016\/j.cca.2025.120574_b0365","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.freeradbiomed.2006.07.006","article-title":"Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells","volume":"41","author":"Negre-Salvayre","year":"2006","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120574_b0370","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0014-5793(81)80422-X","article-title":"Plasma high density lipoproteins inhibit the activation of coagulation factor X by factor VIIa and tissue factor","volume":"132","author":"Carson","year":"1981","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.cca.2025.120574_b0375","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1161\/01.ATV.14.11.1775","article-title":"HDL and apolipoprotein A-I protect erythrocytes against the generation of procoagulant activity","volume":"14","author":"Epand","year":"1994","journal-title":"Arterioscler. Thromb."},{"issue":"11","key":"10.1016\/j.cca.2025.120574_b0380","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1161\/01.RES.0000225982.01988.93","article-title":"Endothelial and antithrombotic actions of HDL","volume":"98","author":"Mineo","year":"2006","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.cca.2025.120574_b0385","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cvr\/cvu137","article-title":"High-density lipoprotein as a modulator of platelet and coagulation responses","volume":"103","author":"van der Stoep","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.cca.2025.120574_b0390","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1172\/JCI116349","article-title":"In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia","volume":"91","author":"Roma","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.cca.2025.120574_b0395","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/01.ATV.19.2.378","article-title":"Inhibition of arterial thrombus formation by ApoA1 Milano","volume":"19","author":"Li","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.cca.2025.120574_b0400","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1161\/STROKEAHA.119.027898","article-title":"Protective effect of ApoA1 (Apolipoprotein A1)-Milano in a Rat Model of Large Vessel Occlusion Stroke","volume":"51","author":"Ducroux","year":"2020","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.cca.2025.120574_b0405","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1681\/ASN.2019111205","article-title":"CKD increases carbonylation of HDL and is associated with impaired antiaggregant properties","volume":"31","author":"Florens","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"25","key":"10.1016\/j.cca.2025.120574_b0410","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1161\/CIRCULATIONAHA.116.025678","article-title":"Cholesterol efflux capacity, high-density lipoprotein particle number, and incident cardiovascular events: an analysis from the JUPITER trial (justification for the use of statins in prevention: an intervention trial evaluating Rosuvastatin)","volume":"135","author":"Khera","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2025.120574_b0415","first-page":"e3810","article-title":"Cholesterol efflux assay","volume":"61","author":"Low","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"2","key":"10.1016\/j.cca.2025.120574_b0420","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20221519","article-title":"Development and validation of novel automatable assay for cholesterol efflux capacity","volume":"43","author":"Mutsuda","year":"2023","journal-title":"Biosci. Rep."},{"issue":"11","key":"10.1016\/j.cca.2025.120574_b0425","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1194\/jlr.D086884","article-title":"A new method for measuring cholesterol efflux capacity uses stable isotope-labeled, not radioactive-labeled, cholesterol","volume":"60","author":"Shimizu","year":"2019","journal-title":"J. Lipid Res."},{"issue":"7","key":"10.1016\/j.cca.2025.120574_b0430","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S2213-8587(15)00126-6","article-title":"Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study","volume":"3","author":"Saleheen","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"25","key":"10.1016\/j.cca.2025.120574_b0435","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2025.120574_b0440","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.774418","article-title":"Cholesterol efflux capacity and its association with adverse cardiovascular events: a systematic review and meta-analysis","volume":"8","author":"Lee","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.cca.2025.120574_b0445","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.P120001000","article-title":"Lipid and metabolic syndrome traits in coronary artery disease: a Mendelian randomization study","volume":"62","author":"Thomas","year":"2021","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2025.120574_b0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2022.02.012","article-title":"The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity","volume":"345","author":"Asztalos","year":"2022","journal-title":"Atherosclerosis"},{"issue":"16","key":"10.1016\/j.cca.2025.120574_b0455","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/eurheartj\/ehac605","article-title":"High-density lipoprotein revisited: biological functions and clinical relevance","volume":"44","author":"von Eckardstein","year":"2023","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.cca.2025.120574_b0460","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210281","article-title":"Association of CETP gene polymorphisms and haplotypes with cardiovascular risk","volume":"24","author":"Piko","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.cca.2025.120574_b0465","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0002-9149(92)91186-8","article-title":"Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease","volume":"70","author":"Drexel","year":"1992","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"10.1016\/j.cca.2025.120574_b0470","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2174\/0929867325666180313114950","article-title":"HDL Dysfunction caused by mutations in apoA-I and other genes that are critical for HDL biogenesis and remodeling","volume":"26","author":"Chroni","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"8","key":"10.1016\/j.cca.2025.120574_b0475","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1194\/jlr.M059089","article-title":"Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity","volume":"56","author":"Vaisar","year":"2015","journal-title":"J. Lipid Res."},{"issue":"7","key":"10.1016\/j.cca.2025.120574_b0480","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/CIRCULATIONAHA.120.045713","article-title":"Associations between high-density lipoprotein particles and ischemic events by vascular domain, sex, and ethnicity: a pooled Cohort analysis","volume":"142","author":"Singh","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2025.120574_b0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154351","article-title":"High-density lipoprotein characteristics and coronary artery disease: a Mendelian randomization study","volume":"112","author":"Prats-Uribe","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2025.120574_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101222","article-title":"HDL subclass proteomic analysis and functional implication of protein dynamic change during HDL maturation","volume":"24","author":"Zhang","year":"2019","journal-title":"Redox Biol."},{"issue":"7","key":"10.1016\/j.cca.2025.120574_b0495","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.116.305485","article-title":"HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export","volume":"116","author":"Du","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2025.120574_b0500","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.atherosclerosis.2016.06.019","article-title":"Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial","volume":"251","author":"Albers","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2025.120574_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111900","article-title":"High-density lipoprotein remodeling by phospholipid nanoparticles improves cholesterol efflux capacity and protects from atherosclerosis","volume":"141","author":"Kudinov","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.cca.2025.120574_b0510","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1161\/ATVBAHA.113.301468","article-title":"Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities","volume":"33","author":"Camont","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.cca.2025.120574_b0515","doi-asserted-by":"crossref","first-page":"10915","DOI":"10.1038\/s41598-022-15192-9","article-title":"The profile of HDL-C subfractions and their association with cardiovascular risk in the Hungarian general and Roma populations","volume":"12","author":"Piko","year":"2022","journal-title":"Sci. Rep."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989812500453X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989812500453X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T13:16:52Z","timestamp":1763039812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989812500453X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":103,"alternative-id":["S000989812500453X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120574","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-density lipoprotein in cardiovascular diseases: From high quantity to high quality","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120574"}}